Spine News and Research

RSS

Schizophrenia: Insight into late development of symptoms

In reports of two new studies, researchers led by Johns Hopkins say they have identified the mechanisms rooted in two anatomical brain abnormalities that may explain the onset of schizophrenia and the reason symptoms don't develop until young adulthood. Both types of anatomical glitches are influenced by a gene known as DISC1, whose mutant form was first identified in a Scottish family with a strong history of schizophrenia and related mental disorders. The findings could lead to new ways to treat, prevent or modify the disorder or its symptoms.

26 Feb 2010

Interventional radiologists to highlight scientific advances, new discoveries at 35th Annual Scientific Meeting

Interventional radiologists-minimally invasive specialists-will share scientific advances and new discoveries in treating a host of diseases at the Society of Interventional Radiology's 35th Annual Scientific Meeting March 13󈝾 at the Tampa Convention Center, Tampa, Fla. This year's meeting theme is "IR Innovation"-one that celebrates the remarkable inventiveness of interventional radiologists.

25 Feb 2010

CHOP and AIAM collaborate to develop more accurate child crash test dummies

A research report released today by The Children's Hospital of Philadelphia (CHOP) and the Association of International Automobile Manufacturers, Inc. (AIAM) details CHOP's cutting-edge work with academic and industry collaborators to develop more accurate child crash test dummies, called child anthropometric test devices (ATD's).

25 Feb 2010

BCBSF to be IPG's designated implantable device management vendor for extensive provider network

Implantable Provider Group is pleased to announce a significant agreement with Blue Cross and Blue Shield of Florida, Inc. to be its designated implantable device management vendor for its extensive provider network. IPG will handle device coordination, billing, replacement, tracking, and other services for BCBSF’s statewide ambulatory surgery center (ASC) network.

25 Feb 2010

Low doses of lasofoxifene reduce all common problems in postmenopausal women: Study

Low doses of the medication lasofoxifene can reduce the risk of vertebral and non-vertebral fractures, ER-positive breast cancer, coronary heart disease and stroke in postmenopausal women with osteoporosis. That's the finding of a new study in the latest issue of the New England Journal of Medicine.

25 Feb 2010

Observational study on mild demonstrates acute safety of procedure in treatment of LSS

Medical device company Vertos Medical Inc. has reported that an observational study on mild, published in the January/February 2010 issue of the peer-reviewed journal Pain Physician, has demonstrated the acute safety of the procedure in the treatment of lumbar spinal stenosis (LSS).

24 Feb 2010

HealthGrades names Good Samaritan Hospital as One of America’s 50 Best Hospitals in 2010

Good Samaritan Hospital in Los Angeles is named as One of America’s 50 Best Hospitals in 2010 by HealthGrades, Inc., the nation’s leading independent healthcare ratings organization.

24 Feb 2010

ViiV Healthcare highlights S/GSK1349572, SELZENTRY and EPZICOM for HIV/AIDS at 17th CROI

At the 17th Conference on Retroviruses and Opportunistic Infections (CROI), ViiV Healthcare presented new data across its broad range of investigational and current medicines for the treatment of HIV/AIDS. Highlighted data at the conference included an oral presentation on the investigational integrase inhibitor, S/GSK1349572, as well as data presentations on SELZENTRY® (maraviroc) and EPZICOM® (abacavir/lamivudine).

24 Feb 2010

Medtronic third-quarter revenues up by 10%

Medtronic, Inc. today reported financial results for the third quarter of fiscal year 2010, which ended January 29, 2010.

23 Feb 2010

More research needed for osteoporosis treatments

Dr. Angelo Malamis says that 90 percent of his patients who have undergone a treatment called balloon kyphoplasty for vertebral fractures report significant reductions in pain and disability.

23 Feb 2010

Amedica, Orthopaedic Synergy sign SiN articulating hip and knee implant Joint Venture Development Agreement

Amedica Corporation (AC), a spinal and orthopaedic implant and instrument company focused on unique silicon nitride (SiN) ceramic technologies, announced today an agreement with Orthopaedic Synergy, Inc. (OSI), a holding company for OMNIlife Science™ and Enztec, both global designers, manufacturers and distributors of leading edge reconstructive surgery implants and instrumentation.

22 Feb 2010

Emory School of Medicine to enroll nearly 1,140 people for Phase III clinical trial of progesterone for TBI

Researchers at 17 medical centers across the country soon will begin using the hormone progesterone to treat patients who experience traumatic brain injury (TBI). The treatment is part of a randomized, double-blind Phase III clinical trial that will enroll approximately 1,140 people over a three- to six-year period beginning in March, 2010. The trial is funded by a grant to Emory University from the National Institutes of Health.

20 Feb 2010

SSHS selects Eclipsys’ Sunrise Enterprise suite of solutions for integrating EHR across multiple care venues

Eclipsys Corporation®, The Outcomes Company®, today announced that Sound Shore Health System (SSHS) will undergo an accelerated activation of Eclipsys’ Sunrise Enterprise™ integrated suite of solutions at both its Sound Shore Medical Center of Westchester (New Rochelle, NY) and Mount Vernon Hospital (Mount Vernon, NY) facilities.

19 Feb 2010

Insight Imaging to provide Enterprise Solutions to Progressive Imaging Center

Insight Imaging announced today that it reached a three-year agreement to provide Insight Imaging Enterprise Solutions to the Progressive Imaging Center located on the campus of Clara Maass Medical Center in Belleville, New Jersey, an affiliate of the Saint Barnabas Health Care System, New Jersey’s largest not-for-profit integrated health care delivery system.

19 Feb 2010

Anulex Technologies announces the commercial availability of Xclose Plus Tissue Repair System

Anulex Technologies, Inc., a privately held medical device manufacturer focusing on spinal disc Preservation & Anular Repair™ products, announced the commercial availability of the Xclose™ Plus Tissue Repair System at the AANS/CNS Joint Section on Disorders of the Spine and Peripheral Nerves meeting in Orlando, Florida.

18 Feb 2010

Fourth-quarter and fiscal year 2009 results announced by DJO Incorporated

DJO Incorporated, a global provider of medical device solutions for musculoskeletal health, vascular health and pain management, today announced financial results for its operating subsidiary, DJO Finance LLC (“DJOFL”), for the fourth quarter and fiscal year ended December 31, 2009. ReAble Therapeutics, Inc. (“ReAble”) acquired DJO Incorporated (“DJO Opco”) in a transaction completed on November 20, 2007 (the “DJO Merger”).

18 Feb 2010

Vertebroplasty effective in treatment of VCFs

The results of a study of more than 4500 patients from six Italian EVEREST (European Vertebroplasty Research Team) Centers (Dr. G.C. Anselmetti-Candiolo Torino, Dr. G. Bonaldi-Bergamo, Dr. P. Carpeggiani-Pisa, Dr. S. Masala-Roma, Dr. M. Muto-Napoli,) confirms the effectiveness of vertebroplasty in treating vertebral compression fractures (VCFs), finding that the procedure provides significant and sustained pain relief.

18 Feb 2010

Gilead Sciences’ “Quad” regimen for HIV exhibits antiretroviral activity comparable to Atripla

Gilead Sciences, Inc. announced Phase II clinical trial results today showing that its investigational fixed-dose single-tablet “Quad” regimen of elvitegravir, GS 9350 (cobicistat) and Truvada® (emtricitabine and tenofovir disoproxil fumarate) for the treatment of HIV infection exhibited antiretroviral activity comparable to that of Atripla® (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg).

18 Feb 2010

Results indicate deficiencies in end-of-life care across U.S.

Approximately 66 percent of respondents to a Maryland telephone survey do not have advance medical directives, according to a new report by researchers from the Johns Hopkins Bloomberg School of Public Health's Department of Health Policy and Management.

18 Feb 2010

Single test is not enough for making accurate diagnosis of disc herniation

While lower back pain ranks as a common cause of disability in the United States, determining what causes a person's back pain is often challenging. A new Cochrane review on diagnosing back pain finds that no single diagnostic test is good at discriminating between patients who have a herniated disc and patients who do not, according to lead author Danielle van der Windt.

18 Feb 2010

Spine News and Research

Schizophrenia: Insight into late development of symptoms

Interventional radiologists to highlight scientific advances, new discoveries at 35th Annual Scientific Meeting

CHOP and AIAM collaborate to develop more accurate child crash test dummies

BCBSF to be IPG's designated implantable device management vendor for extensive provider network

Low doses of lasofoxifene reduce all common problems in postmenopausal women: Study

Observational study on mild demonstrates acute safety of procedure in treatment of LSS

HealthGrades names Good Samaritan Hospital as One of America’s 50 Best Hospitals in 2010

ViiV Healthcare highlights S/GSK1349572, SELZENTRY and EPZICOM for HIV/AIDS at 17th CROI

Medtronic third-quarter revenues up by 10%

More research needed for osteoporosis treatments

Amedica, Orthopaedic Synergy sign SiN articulating hip and knee implant Joint Venture Development Agreement

Emory School of Medicine to enroll nearly 1,140 people for Phase III clinical trial of progesterone for TBI

SSHS selects Eclipsys’ Sunrise Enterprise suite of solutions for integrating EHR across multiple care venues

Insight Imaging to provide Enterprise Solutions to Progressive Imaging Center

Anulex Technologies announces the commercial availability of Xclose Plus Tissue Repair System

Fourth-quarter and fiscal year 2009 results announced by DJO Incorporated

Vertebroplasty effective in treatment of VCFs

Gilead Sciences’ “Quad” regimen for HIV exhibits antiretroviral activity comparable to Atripla

Results indicate deficiencies in end-of-life care across U.S.

Single test is not enough for making accurate diagnosis of disc herniation

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News